Marker Therapeutics (MRKR) Interest & Investment Income (2018 - 2026)
Marker Therapeutics (MRKR) reported Interest & Investment Income of $112,558 for Q2 2026, down 12.1% from $128,025 a year earlier and down 15.3% from the prior quarter.
Powered by 
Analysis
Marker Therapeutics (MRKR) Interest & Investment Income (2018 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Marker Therapeutics' Interest & Investment Income came in at $549,139, up 20.4% year-over-year; for FY2025, it was $594,206, up 36.0% from FY2024.
- Interest & Investment Income has a five-year compound annual growth rate of 31.9% (FY2020 to FY2025).
- By year, Interest & Investment Income came in at $437,010 in FY2024 (-18.9%), $539,158 in FY2023 (+117.3%), $248,063 in FY2022 and $5,700 in FY2021 (-96.2%).
- The Q2 2026 figure ranks as the lowest quarterly Interest & Investment Income since Q4 2024.
- Year over year, Interest & Investment Income gained in four of the last eight quarters, with growth averaging 4.8%.
- The high point for year-over-year Interest & Investment Income in five years was Q2 2024 (growth of 228.9%); the low point was Q3 2021 (a decline of 83.1%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $132,889 (Q1 2026), $165,628 (Q4 2025) and $138,064 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Marker Therapeutics | 17.53 Mn | -42.37 Mn | - | 112,558.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 112,558.00 |
| Mar 31, 2026 | 132,889.00 |
| Dec 31, 2025 | 165,628.00 |
| Sep 30, 2025 | 138,064.00 |
| Jun 30, 2025 | 128,025.00 |
| Mar 31, 2025 | 162,489.00 |
| Dec 31, 2024 | 73,746.00 |
| Sep 30, 2024 | 91,681.00 |
| Jun 30, 2024 | 115,388.00 |
| Mar 31, 2024 | 156,195.00 |
| Dec 31, 2023 | 201,339.00 |
| Sep 30, 2023 | 218,085.00 |
| Jun 30, 2023 | 35,080.00 |
| Mar 31, 2023 | 84,654.00 |
| Dec 31, 2022 | 109,410.00 |
| Sep 30, 2022 | 99,750.00 |
| Jun 30, 2022 | 35,786.00 |
| Mar 31, 2022 | 3,117.00 |
| Dec 31, 2021 | 969.00 |
| Sep 30, 2021 | 791.00 |
API Access
Marker Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=MRKR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "MRKR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=MRKR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();